Bionpharma Atovaquone Oral Suspension - recalled due to Cohnella bacteria, United States
2 weeks ago •source fda.gov • details
Recall notice
3 years ago • business
Regulatory Report
110 East Wilshire Avenue, Fullerton, 92832 California, United States
1. T8 CCR § 3203(a)(4) and (a)(6) - Employees tested positive for Covid-19 and Employer not addressing the issue effectively. Employees concerned with potential exposure to Covid-19 in the workplace. Social distancing not enforced in the workplace. 2. T8 CCR § 3203(a)(2) -Face coverings not enforced in the workplace.2 weeks ago •source fda.gov • details
Recall notice
1 day ago •reported by user-jdtk5191 • details
4 weeks ago •reported by user-bttnb287 • details
2 weeks ago •reported by user-gvfpb533 • details
2 days ago •reported by user-kmbj7529 • details
4 weeks ago •reported by user-tbjg7863 • details
2 weeks ago •reported by user-bkjf1497 • details
1 week ago •source fda.gov • details
Recall notice
2 weeks ago •reported by user-nnwjt741 • details
2 weeks ago •reported by user-hqfr4982 • details
Search